NewsBenzingaCreative Medical Technology Acquires 4M Additional BioDefense Stock For $200K Cash And 1M Shares, Raising Ownership To 80% Creative Medical Technology Acquires 4M Additional BioDefense Stock For $200K Cash And 1M Shares, Raising Ownership To 80% Benzinga 2026.09.25 21:13 (GMT+0) Open on Benzinga Other news TD Cowen raises Strive price target to $56 as BTC accumulation beats expectations Sui developer Mysten Labs establishes AI business unit; President Kevin Boon to become CEO Crypto industry PACs have poured over $52 million into the Ohio Senate race Tough Trading Leaves Indices In The Red OpenAI poaches another core sales executive from SpaceX's AI division Kevin Boon Succeeds Evan Cheng as Mysten Labs CEO
